Founder Chairman of Wockhardt group, Dr. Habil Khorakiwala was presented the Lifetime Achievement Award at the 10th Integrated Health & Wellbeing (IHW) Summit, a premier think-tank council engaged in public health advocacy and focused on promoting health, wellness and holistic well-being.
The esteemed advisory board recognized the exceptional contributions and lifelong dedication of Dr. Habil Khorakiwala to transform the healthcare landscape in India and globally.
The IHW Council in its statement lauded his visionary leadership as the Founder Chairman of Wockhardt which has been pivotal in advancing healthcare accessibility and quality. The Council acknowledged his unparalleled contributions towards unwavering commitment to innovation, patient care and integration of global standards setting a new benchmark in the industry. His pioneering efforts has maintained a balance between affordability and excellence in healthcare, thus leaving a lasting impact on countless lives. His extraordinary leadership serves as an inspiration fostering continued progress towards the shared vision of holistic health and wellbeing for all.
Under the visionary leadership of Dr. Habil Khorakiwala over the period of 25 years, Wockhardt has focused its research efforts in the area of discovering novel medicines for multi-drug resistant infections. This has resulted in a portfolio of 6 novel antibiotics at various stages of clinical development and commercialization, each have been granted Qualified Infectious Disease Product status by the US FDA. Wockhardt's flagship novel mechanism-based antibiotic, ZaynichTM (Zidebactam/Cefepime), designed to target extremedrug resistant Gram negative infections, is undergoing a global Phase 3 study. Zaynich has already saved lives of more than 35 critically ill patients under compassionate use over last one year and is also being evaluated in a clinical study involving patients with documented meropenem-resistant infections.
Dr. Habil Khorakiwala is also ex-President of FICCI & has played an important role in India's bilateral relations & nation building effort.
On his behalf, the award was accepted by Dr. Huzaifa Khorakiwala (Executive Director of Wockhardt and CEO of Wockhardt Foundation) at the 10th edition of Integrated Health and Wellbeing Summit & Global Health Leaders Awards held on 21st September, 2024, at the Hyatt Regency in Deira Dubai.
Shares of Wockhardt Limited was last trading in BSE at Rs. 1004.45 as compared to the previous close of Rs. 956.65. The total number of shares traded during the day was 23156 in over 475 trades.
The stock hit an intraday high of Rs. 1004.45 and intraday low of 955.00. The net turnover during the day was Rs. 22683944.00. |
